ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Senate Committee Approves $27 Billion for NIH, $4.6 Billion for NCI

August 2, 2002

SEC Notifies ImClone It May Bring Action Against Company

June 21, 2002

Peter Shields Named Deputy Director At Ohio State

September 16, 2011

Seattle Panel Meeting Generate More Support For Increased Outreach Funding, Consortium Approached

November 2, 1984

Dipersio Is Chief Of Oncology At Washington University.

July 14, 2000

NCI Payline To Jump To 25th Percentile For A Portion Of Grants, Director Says

April 24, 2009